{"id":"W2592509339","doi":"10.1111/epi.13709","title":"<scp>ILAE</scp> classification of the epilepsies: Position paper of the <scp>ILAE</scp> Commission for Classification and Terminology","year":2017,"lang":"en","type":"article","venue":"Epilepsia","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":4881,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; BC Children's Hospital; University of British Columbia","funders":"Cilag; UCB Pharma; National Health and Medical Research Council; Medical Research Council; Canadian Institutes of Health Research; University of California, Los Angeles; Sun Pharma; Universidade Católica de Brasília; Fundação Bial; Eisai; Epilepsy Research UK; NeuroPace; National Institutes of Health; Mylan; Supernus Pharmaceuticals; Zynerba Pharmaceuticals; Upsher-Smith; Division of Arctic Sciences; Sage Therapeutics; Epilepsiatutkimussäätiö; Dravet Syndrome UK; Zogenix; Alva Foundation; Lundbeckfonden; U.S. Department of Defense; Yorkhill Children’s Charity; GW Pharmaceuticals; Sanofi; Citizens United for Research in Epilepsy; Novartis; Acorda Therapeutics; Stockholms Läns Landsting; Takeda Pharmaceuticals U.S.A.; Pfizer; Humanities Research Center, Rice University; Ultragenyx Pharmaceutical; GlaxoSmithKline; Vertex Pharmaceuticals; March of Dimes Foundation; National Institute of Neurological Disorders and Stroke; CURE Childhood Cancer; H. Lundbeck A/S; Sunovion","keywords":"Epilepsy; Terminology; Etiology; Medicine; Epilepsy syndromes; Generalized epilepsy; Pediatrics; Intensive care medicine; Psychiatry","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}